• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个伦理问题:兜售自体干细胞疗法有违专业标准。

A question of ethics: selling autologous stem cell therapies flaunts professional standards.

作者信息

Munsie Megan, Hyun Insoo

机构信息

Stem Cells Australia, Department of Anatomy and Neuroscience, The University of Melbourne, Parkville 3010, Australia.

Department of Bioethics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106-4976, USA.

出版信息

Stem Cell Res. 2014 Nov;13(3 Pt B):647-53. doi: 10.1016/j.scr.2014.04.014. Epub 2014 Apr 29.

DOI:10.1016/j.scr.2014.04.014
PMID:24857592
Abstract

The idea that the body's own stem cells could act as a repair kit for many conditions, including cardiac repair, underpins regenerative medicine. While progress is being made, with hundreds of clinical trials underway to evaluate possible autologous cell-based therapies, some patients and physicians are not prepared to wait and are pursuing treatments without evidence that the proposed treatments are effective, or even safe. This article explores the inherent tension between patients, practitioners and the need to regulate the development and commercialization of new cellular therapies--even when the cells come from the patient.

摘要

人体自身的干细胞可以充当治疗多种疾病(包括心脏修复)的修复工具,这一理念是再生医学的基础。虽然目前正在取得进展,有数百项临床试验正在进行,以评估可能的自体细胞疗法,但一些患者和医生不愿等待,在没有证据证明所提议的治疗方法有效甚至安全的情况下就寻求治疗。本文探讨了患者、从业者之间的内在矛盾,以及对新细胞疗法的开发和商业化进行监管的必要性——即使这些细胞来自患者自身。

相似文献

1
A question of ethics: selling autologous stem cell therapies flaunts professional standards.一个伦理问题:兜售自体干细胞疗法有违专业标准。
Stem Cell Res. 2014 Nov;13(3 Pt B):647-53. doi: 10.1016/j.scr.2014.04.014. Epub 2014 Apr 29.
2
FDA's claims over stem cells upheld.美国食品药品监督管理局对干细胞的声明得到支持。
Nature. 2012 Aug 2;488(7409):14. doi: 10.1038/488014a.
3
Direct-to-consumer marketing of stem cell interventions by Canadian businesses.加拿大企业面向消费者的干细胞干预疗法营销。
Regen Med. 2018 Sep;13(6):643-658. doi: 10.2217/rme-2018-0033. Epub 2018 Sep 26.
4
Vulnerabilities and the Use of Autologous Stem Cells for Medical Conditions in Australia.澳大利亚自体干细胞在医疗状况中的应用及相关脆弱性
Perspect Biol Med. 2018;61(1):76-89. doi: 10.1353/pbm.2018.0028.
5
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine.在线干细胞诊所:干细胞医学面向消费者的宣传
Cell Stem Cell. 2008 Dec 4;3(6):591-4. doi: 10.1016/j.stem.2008.11.001.
6
Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.未经证实的基于干细胞的干预措施以及在多个利益相关者之间达成妥协政策。
BMC Med Ethics. 2015 Nov 4;16(1):75. doi: 10.1186/s12910-015-0069-x.
7
Stem cell research and therapies in Argentina: the legal and regulatory approach.阿根廷的干细胞研究与治疗:法律与监管方法。
Stem Cells Dev. 2013 Dec;22 Suppl 1:40-3. doi: 10.1089/scd.2013.0431.
8
The deadly business of an unregulated global stem cell industry.无监管的全球干细胞产业的致命生意。
J Med Ethics. 2017 Nov;43(11):744-746. doi: 10.1136/medethics-2016-104046. Epub 2017 Mar 29.
9
Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.关于日本再生医学安全法规的制定和影响的思考。
Stem Cell Reports. 2021 Jun 8;16(6):1425-1434. doi: 10.1016/j.stemcr.2021.04.017. Epub 2021 May 20.
10
Editors' Introduction to the Special Section on Ethics, Policy, and Autologous Cellular Therapies.
Perspect Biol Med. 2018;61(1):1-6. doi: 10.1353/pbm.2018.0023.

引用本文的文献

1
A transcriptomic analysis of dental pulp stem cell senescence in vitro.牙髓干细胞衰老的转录组学分析。
Biomed Eng Online. 2024 Oct 18;23(1):102. doi: 10.1186/s12938-024-01298-w.
2
The Direct to Consumer Stem Cell Market and the Role of Primary Care Providers in Correcting Misinformation.直接面向消费者的干细胞市场和初级保健提供者在纠正错误信息方面的作用。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221121460. doi: 10.1177/21501319221121460.
3
Different kinds of stem cells in the development of SARS-CoV-2 treatments.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)治疗发展过程中的不同种类干细胞。
World J Stem Cells. 2021 May 26;13(5):439-451. doi: 10.4252/wjsc.v13.i5.439.
4
Challenging misinformation and engaging patients: characterizing a regenerative medicine consult service.挑战错误信息,与患者互动:描绘再生医学咨询服务。
Regen Med. 2020 Mar;15(3):1427-1440. doi: 10.2217/rme-2020-0018. Epub 2020 Apr 22.
5
Science, ethics and communication remain essential for the success of cell-based therapies.科学、伦理和沟通对于基于细胞的治疗的成功仍然至关重要。
Brain Circ. 2016 Jul-Sep;2(3):146-151. doi: 10.4103/2394-8108.192525. Epub 2016 Oct 18.
6
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) Regulates the Expression of B-Cell Lymphoma/Leukemia-2 (Bcl-2) and Promotes the Survival of Mesenchymal Stem Cells (MSCs) via PGC-1α/ERRα Interaction in the Absence of Serum, Hypoxia, and High Glucose Conditions.过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)在无血清、缺氧和高糖条件下,通过PGC-1α/雌激素相关受体α(ERRα)相互作用调节B细胞淋巴瘤/白血病-2(Bcl-2)的表达并促进间充质干细胞(MSC)的存活。
Med Sci Monit. 2017 Jul 16;23:3451-3460. doi: 10.12659/msm.902183.
7
Cranioplasty with Adipose-Derived Stem Cells, Beta-Tricalcium Phosphate Granules and Supporting Mesh: Six-Year Clinical Follow-Up Results.脂肪来源干细胞、β-磷酸三钙颗粒和支撑网颅骨成形术:六年临床随访结果。
Stem Cells Transl Med. 2017 Jul;6(7):1576-1582. doi: 10.1002/sctm.16-0410. Epub 2017 May 15.
8
Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine.打印人体器官?医学 3D 生物打印引发的伦理和监管问题。
Sci Eng Ethics. 2018 Feb;24(1):73-91. doi: 10.1007/s11948-017-9874-6. Epub 2017 Feb 9.
9
Current Concepts in Treatment of Patellofemoral Osteochondritis Dissecans.髌股关节剥脱性骨软骨炎治疗的当前概念
Int J Sports Phys Ther. 2016 Dec;11(6):903-925.
10
Biological Therapies in Regenerative Sports Medicine.再生运动医学中的生物疗法。
Sports Med. 2017 May;47(5):807-828. doi: 10.1007/s40279-016-0620-z.